Browsing publications by Dr Sally Coulthard

Newcastle AuthorsTitleYearFull text
Dr Sally Coulthard
Professor Ann Daly
HLA-DRB1*16:01-DQB1*05:02 is a novel genetic risk factor for flupirtine-induced liver injury2016
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Christopher Redfern
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients2016
Dr Sally Coulthard
Philip Berry
Sarah McGarrity
Dr Christopher Redfern
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients2016
Dr Sally Coulthard
Professor Ann Daly
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting2016
Dr Sally Coulthard
Nomenclature for alleles of the thiopurine methyltransferase gene2013
Professor Ann Daly
Dr Gareth Veal
Dr David Jamieson
Dr Sally Coulthard
Pharmacogenomics research at Newcastle University2012
Dr Sally Coulthard
Dr Christopher Redfern
Svante Vikingsson
Dr Malin Lindqvist Appell
Professor Andy Hall
et al.
Increased Sensitivity to Thiopurines in Methylthioadenosine Phosphorylase-Deleted Cancers2011
Tomasz Zaremba
Huw Thomas
Mike Cole
Dr Sally Coulthard
Professor Ruth Plummer
et al.
Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers2011
Dr Sally Coulthard
Dr Christopher Redfern
Dr Linda Hogarth
Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers [abstract]2010
Dr Sally Coulthard
Thiopurines: Factors influencing toxicity and response2010
1234